(MENAFN- Ameliorate Digital Consultancy)
As per a new industry analysis by Fact.MR, a market research and competitive intelligence provider, the hysteroscopes market is currently valued at US$ 265.5 million and is expected to increase at a CAGR of 5% from 2022 to 2032.
Hysteroscopy is a procedure that is used to look inside the uterus. Acute cramping, heavy or irregular bleeding, irregular pregnancies, a misplaced intrauterine implant, or problems conceiving are among the conditions it is used to identify and treat. Surgical and diagnostic procedures also use it. While hysteroscopes used during surgical hysteroscopy are intended to remove deformities like polyps and fibroids, those used during diagnostic hysteroscopy are used to look for any uterine abnormalities.
Download a Sample Copy of This Report
Key Takeaways from Market Study
The global market for hysteroscopes is projected to reach US$ 432.5 million by 2032. China's market for hysteroscopes is predicted to expand at a high CAGR of 8% during the forecast period. Sales of rigid hysteroscopes are likely to increase at a CAGR of 6% during the next 10 years. Sales of flexible hysteroscopes are expected to progress at a CAGR of 4% during the forecast period.
Why are Suppliers of Hysteroscopes Attracted to North America?
North American nations with advanced healthcare systems include the United States and Canada. As a result, significant resources are spent on researching and creating more effective, less invasive technology.
The need for diagnostic hysteroscopes is growing in the North American region due to an increase in uterine or endometrial cancer cases.
Uterine cancer, also known as endometrial cancer, is likely to affect 65,950 individuals in the United States in 2022, according to the American Society of Clinical Oncology's publication Uterine Cancer: Statistics 2022. According to a report from the international journal of gynecology and obstetrics titled“Cancer of the corpus uteri: 2021 update” which was released in October 2021, endometrial cancer, is the most common form of cancer found in the female genital tract and is the fifth most commonly seen cancer in women after breast, colorectal, lung, and non-basal skin cancer, and is most common in North America.
As a result, there will be a greater need for diagnostic and therapeutic hysteroscopy equipment for uterine or endometrial cancer treatment, which will accelerate hysteroscopy instruments market growth in the region.
An increase in female ailments such as transcervical sterilisation, irregular uterine bleeding, and fertility issues is expected to boost hysteroscope sales. Hysteroscopy is increasingly being employed in reproductive aid and is used to assess uterine disorders. Therefore, it is anticipated that an increase in the number of couples choosing Assisted Reproductive Technology (ART) operations will fuel hysteroscope sales.
The benefits of hysteroscopy include quick recovery, fewer hospital stays, and little blood loss. The procedure is recommended because patients can return to their regular activities in a smaller number of days than with typical invasive procedures and thus, there is little post-operative discomfort.
On the flip side, the lack of awareness regarding hysteroscope procedures in developing countries and the high cost of advanced hysteroscopes are expected to limit product sales growth to some extent.
Prominent Key Players
B. Braun Melsungen AG Boston Scientific Corporation Ethicon US LLC Hologic, Inc. Karl Storz GmbH & Co. KG Medtronic PLC Olympus Corporation Richard Wolf GmbH Stryker Corporation The Cooper Companies, Inc.
Winning Strategy
For improved visualisation, top manufacturers are developing HD optical lenses with higher resolution and made of specialised sapphire glass. To draw in more clients, they are also developing hysteroscopes with a semi-flexible shaft. Other well-liked tactics they use to increase their market shares include competitive pricing and smart collaborations.
In Europe, Africa, and the Middle East, Hologic, Inc. launched its upgraded Omni suite in September 2021. It is a comprehensive gynaecological surgical product created to enhance diagnostic and operative hysteroscopy.
Key Segments of Hysteroscopes Industry Research
By Product Type: By Application: Myomectomy Diagnostic Operative Polypectomy Endometrial Ablation
By End User: Hospitals Ambulatory Surgical Centers Gynecology Clinics Others
By Region: North America Latin America Europe East Asia South Asia & Oceania MEA
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: